Hyman Charles D Becton Dickinson & CO Transaction History

Hyman Charles D

  • $1.79 Billion
  • Q2 2024

A detailed history of Hyman Charles D transactions in Becton Dickinson & CO stock. As of the latest transaction made, Hyman Charles D holds 2,550 shares of BDX stock, worth $582,649. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,550
Previous 2,554 0.16%
Holding current value
$582,649
Previous $631,000 5.71%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024
SELL
$225.07 - $246.17 $900 - $984
-4 Reduced 0.16%
2,550 $595,000
Q4 2023

Feb 06, 2024
BUY
$232.24 - $267.23 $31,120 - $35,808
134 Added 5.54%
2,554 $622,000
Q1 2023

May 04, 2023
BUY
$229.71 - $259.35 $57,427 - $64,837
250 Added 11.52%
2,420 $599,000
Q4 2022

Feb 06, 2023
SELL
$218.29 - $256.91 $53,699 - $63,199
-246 Reduced 10.18%
2,170 $552,000
Q3 2020

Oct 26, 2020
SELL
$215.77 - $276.76 $4,962 - $6,365
-23 Reduced 0.94%
2,416 $562,000
Q4 2019

Feb 03, 2020
BUY
$236.45 - $266.82 $5,438 - $6,136
23 Added 0.95%
2,439 $663,000
Q3 2019

Nov 07, 2019
SELL
$230.58 - $256.08 $8,762 - $9,731
-38 Reduced 1.55%
2,416 $611,000
Q1 2019

May 13, 2019
SELL
$206.05 - $248.17 $106,321 - $128,055
-516 Reduced 17.37%
2,454 $613,000
Q2 2018

Aug 06, 2018
SELL
$208.1 - $233.85 $6,034 - $6,781
-29 Reduced 0.97%
2,970 $711,000
Q1 2018

May 07, 2018
SELL
$205.46 - $240.27 $205 - $240
-1 Reduced 0.03%
2,999 $650,000
Q4 2017

Feb 06, 2018
BUY
$189.0 - $222.64 $12,852 - $15,139
68 Added 2.32%
3,000 $642,000
Q2 2017

Aug 14, 2017
BUY
N/A
2,932
2,932 $572,000

Others Institutions Holding BDX

# of Institutions
1,738
Shares Held
249M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Hyman Charles D Portfolio

Follow Hyman Charles D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hyman Charles D, based on Form 13F filings with the SEC.

News

Stay updated on Hyman Charles D with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email